Patients with psoriatic arthritis and comorbid metabolic syndrome show a difficult-to-treat phenotype: another mosaic tile in the definition of a still undefined subset of patients
MetS is strongly associated with a D2T phenotype in PsA, suggesting that metabolic comorbidities contribute to disease severity and treatment resistance. Addressing metabolic dysfunction may be crucial in optimising therapeutic outcomes in PsA management.
Authors
- Marta Gatti (ORCID: https://orcid.org/0000-0003-0627-5243)
- Luca Navarini (ORCID: https://orcid.org/0000-0001-8537-1510)
- Marta Vomero (ORCID: https://orcid.org/0000-0001-9744-5628)
- Annalisa Marino (ORCID: https://orcid.org/0000-0002-2511-7374)
- Damiano Currado (ORCID: https://orcid.org/0000-0003-1815-2304)
- Francesca Saracino
- Roberto Giacomelli (ORCID: https://orcid.org/0000-0003-0670-9638)
- Antonio Orlando (ORCID: https://orcid.org/0000-0002-5418-2255)
- Erika Corberi
- Francesca Trunfio
- Onorina Berardicurti (ORCID: https://orcid.org/0000-0002-2808-1581)
- Vasiliki Liakouli (ORCID: https://orcid.org/0000-0002-7392-9334)
- Lyubomyra Kun
- Leonardo Frascà
- Ludovica Lamberti
Institutions
- Università Campus Bio-Medico (IT)
- Policlinico Umberto I (IT)
- University of Campania "Luigi Vanvitelli" (IT)
- Policlinico Tor Vergata (IT)
- Campus Bio Medico University Hospital (IT)
Publication Details
- Journal
- RMD Open
- Published
- 2025-04-01
- DOI
- https://doi.org/10.1136/rmdopen-2025-005717
- Citations
- 5
- Primary Topic
- Spondyloarthritis Studies and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 8.34